<unk>  is an active vaccine with which patients are immunized with epidermal growth factor <unk> , thus raising antibodies targeting<unk>  itself. The product is also formulated with the Neisseria meningitidis outer protein P64k and Montanide ISA 51 as adjuvants to potentiate the immune response. The epidermal growth factor receptor <unk> R) is hijacked by many types of cancer, including cancers of the lung, colon, kidney, and head and neck. By raising antibodies against<unk> , which is<unk> R's major ligand, the concentrations of<unk>  in the blood are reduced. Thus<unk>  does not target the cancer cells directly, but is expected to work against these cancers by denying the cancers the growth stimulus they require. For this reason, the Roswell Park Comprehensive Cancer Center group thinks that it may prove most useful as a preventive vaccine rather than as a cancer therapy per se.
CimaVax-EGF
Biocitech
ScotSTAR
Alloplant
Poly-MVA
Elastix 
Trafermin
Metab-L